Mr Hemal Mehta
MBBS (LONDON), MA (CAMBRIDGE), FRCOPHTH (UK)
Mr Hemal Mehta
Mr Hemal Mehta is a Consultant Ophthalmic Surgeon at Royal Free London NHS Foundation Trust.
He specialises in medical retina conditions (e.g. age-related macular degeneration and diabetic eye disease) and cataract surgery. Mr Hemal Mehta also participates in the general ophthalmology on call rota at a busy London teaching hospital managing a wide range of ocular pathology.
The clinical research during his fellowships at Sydney Eye Hospital and Moorfields Eye Hospital is the basis of his MD thesis on ‘Novel endpoints in diabetic retinopathy clinical trials’ registered at Cambridge University. He is the Lead for Ophthalmic Clinical Trials Research in his Trust, evaluating emerging therapies, particularly for retinal diseases.
Personal interests: Cricket and Scuba Diving
- Medical retina (including age-related macular degeneration, diabetic eye disease, intravitreal injections and retinal laser therapy)
- Cataract surgery
- General ophthalmology
Like to book an appointment?
Fill out the contact form below or call us on
020 7317 7751 to speak with a member of our team
- Intravitreal injections
- Retinal laser
- YAG laser capsulotomy
- Cataract surgery
- Eyelid Procedures
- Hemal Mehta is the Lead for Ophthalmic Clinical Trials Research in his Trust, evaluating emerging therapies, particularly for retinal diseases. The clinical research during his fellowships at Sydney Eye Hospital and Moorfields Eye Hospital is the basis of his MD thesis on ‘Novel endpoints in diabetic retinopathy clinical trials’ registered at Cambridge University.
Leah N Kim, Hemal Mehta, Daniel Barthelmes, Vuong Nguyen, Mark C Gillies. Meta-analysis of real-world outcomes of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration. Retina 07/2016. DOI: 10.1097/IAE.0000000000001142
Hemal Mehta, Simone Muller, Catherine A Egan, Simona Degli Esposti, Adnan Tufail, Dawn A Sim, Frank G Holz, Winfried M Amoaku, Peter Charbel Issa, Mark C Gillies. Natural history and effect of therapeutic interventions on subretinal fluid causing foveal detachment in macular telangiectasia type 2. British Journal of Ophthalmology 11/2016; DOI: 10.1136/bjophthalmol-2016-309237
Mohamed Katta, Hemal Mehta, Ivan Ho, Ray Garrick, Robert Chong. Optical coherence tomography imaging of optic disc cavernous haemangioma. J Clinical Neuroscience 07/2016. DOI: 10.1016/j.jocn.2016.04.010
Hemal Mehta, Mark C Gillies, Samantha Fraser-Bell: Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macula oedema: a review. Clinical and Experimental Ophthalmology 04/2016; DOI:10.1111/ceo.12757
Samantha Fraser-Bell, Lyndell L Lim, Anna Campain, Hemal Mehta, Christine Aroney, Jaclyn Bryant, Ji Li, Godfrey J Quin, Ian L McAllister, Mark C Gillies: Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study). Ophthalmology 01/2016; DOI:10.1016/j.ophtha.2015.12.012
Hemal Mehta, Samantha Fraser-Bell, Aaron Yeung, Anna Campain, Lyndell L Lim, Godfrey J Quin, Ian L McAllister, Pearse A Keane, Mark C Gillies: Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial. The British journal of ophthalmology 11/2015. DOI:10.1136/bjophthalmol-2015-307797
Hemal Mehta, Mark C Gillies, Samantha Fraser-Bell: Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema. Therapeutic Advances in Chronic Disease 08/2015; 6(5):234-245. DOI:10.1177/2040622315590319
Mark C Gillies, Hemal Mehta, Alan C Bird: Macular Telangiectasia Type 2 Without Clinically Detectable Vasculopathy. Jama Ophthalmology 06/2015. DOI:10.1001/jamaophthalmol.2015.1796
Hemal Mehta, Dawn A Sim, Pearse A Keane, Javier Zarranz-Ventura, Kevin Gallagher, Catherine A Egan, Mark Westcott, Richard W J Lee, Adnan Tufail, Carlos E Pavesio: Structural changes of the choroid in sarcoid- and tuberculosis-related granulomatous uveitis. Eye (London, England) 05/2015; 29(8). DOI:10.1038/eye.2015.65
Hemal Mehta, Samantha Fraser-Bell, Anna Campain, Mark C Gillies: Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema (Protocol). Cochrane database of systematic reviews 03/2015. DOI:10.1002/14651858.CD011599
Cecilia S Lee, Aaron Y Lee, Dawn A Sim, Pearse A Keane, Hemal Mehta, Javier Zarranz-Ventura, Marcus Fruttiger, Catherine A Egan, Adnan Tufail: Reevaluating the Definition of Intraretinal Microvascular Abnormalities and Neovascularization Elsewhere in Diabetic Retinopathy Using Optical Coherence Tomography and Fluorescein Angiography. American Journal of Ophthalmology 10/2014; 159(1). DOI:10.1016/j.ajo.2014.09.041
Dawn A Sim, Pearse A Keane, Hemal Mehta, Simon Fung, Javier Zarranz-Ventura, Marcus Fruttiger, Praveen J Patel, Catherine A Egan, Adnan Tufail: Repeatability and Reproducibility of Choroidal Vessel Layer Measurements in Diabetic Retinopathy Using Enhanced Depth Optical Coherence Tomography. Investigative ophthalmology & visual science 03/2013; 54(4). DOI:10.1167/iovs.12-11085
Mandeep S Sagoo, Hemal Mehta, Andrew J Swampillai, Victoria M L Cohen, Sepideh Z Amin, P Nicholas Plowman, Sue Lightman: Primary Intraocular Lymphoma. Survey of Ophthalmology
Dania Qatarneh, Hemal Mehta, Vickie Lee: Insight into Leber congenital amaurosis: Potential for gene therapy. Expert Review of Ophthalmology 03/2011; 6(2):203-209. DOI:10.1586/eop.11.7
Hemal Mehta, John L Hungerford, David S Gartry, Helen M Herbert, Prithvi Mruthyunjaya: Transpositional Autokeratoplasty in a Patient with Unilateral Choroidal Melanoma and Contralateral Exposure Keratopathy. Ophthalmic Surgery Lasers and Imaging 03/2010; DOI:10.3928/15428877-20100215-41